CPT® Code 86689

The CPT® Code 86689 refers to a confirmatory test for antibodies against human T-lymphotropic virus type I (HTLV-I), human T-lymphotropic virus type II (HTLV-II), or human immunodeficiency virus (HIV) types I and II. This test is crucial for diagnosing infections caused by these viruses, which are known to be sexually transmitted and can also be transmitted through unscreened blood, shared needles, or from mother to child during pregnancy or breastfeeding. HTLV-I and HTLV-II are associated with serious health conditions, including disorders of the bone marrow and blood cells, with HTLV-I specifically linked to adult T-cell leukemia. HIV, on the other hand, compromises the immune system by targeting and destroying CD4 T cells, which are essential for the body’s defense against infections. The progression of HIV can lead to acquired immunodeficiency syndrome (AIDS), the most severe stage of the infection. The testing process typically begins with an enzyme immunoassay (EIA) to detect the presence of antibodies in a blood sample. If the EIA yields a positive result, a confirmatory test is conducted using the Western blot method, which is a more specific immunoassay technique that separates proteins based on size and shape, allowing for the identification of antibodies to HTLV-I, HTLV-II, HIV-I, or HIV-II. This confirmatory testing is essential for accurate diagnosis and subsequent management of these viral infections.